SEARCH

SEARCH BY CITATION

References

  • 1
    Tohen M, Zhang F, Taylor CC, Burns P, Zarate C, Sanger T, Tollefson G. A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. J Affect Disord 2001;65:8593.
  • 2
    Goodwin GM. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003;17:149173.
  • 3
    American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159:150.
  • 4
    Emilien G, Maloteaux JM, Seghers A, Charles G. Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis. Eur Neuropsychopharmacol 1996;6:245252.
  • 5
    Bowden CL, Davis J, Morris D, Swann A, Calabrese J, Lambert M, Goodnick P. Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania. Depress Anxiety 1997;6:2630.
  • 6
    Poolsup N, Li Wan PA, De Oliveira IR. Systematic overview of lithium treatment in acute mania. J Clin Pharm Ther 2000;25:139156.
  • 7
    Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 1998;155:1221.
  • 8
    Ghaemi SN, Goodwin FK. Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature. J Clin Psychopharmacol 1999;19:354361.
  • 9
    Rendell JM, Gijsman HJ, Keck P, Goodwin GM, Geddes JR. Olanzapine alone or in combination for acute mania. Cochrane Database of Systamatic Reviews 2003;1:CD004040. DOI: 10.1002/14651858.CD004040.
  • 10
    Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Health Technol Assess 2004;8:iii187.
  • 11
    Bowden CL. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder. J Clin Psychiatry 2005;66(suppl. 3):1219.
  • 12
    The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Updated March, 2005; 4.2.4.2005.
  • 13
    Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:4246.
  • 14
    Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: EggerM, Davey SmithG, AltmanDG, eds. Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001:285312.
  • 15
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557560.
  • 16
    Mullen J, Devine N, Sweitzer D. Quetiapine adjunctive therapy for acute mania associated with bipolar disorder (SIAM). Program and abstracts of the Fifth International Conference on Bipolar Disorder, June 12–14, 2003, Pittsburgh, PA. Abstract P139, 2003.
  • 17
    Sussman N, Mullen J, Sweitzer De. Mania remission rates and euthymia with quetiapine combination therapy. Eur Psychiatry 2005;20:S140S141.
  • 18
    Yatham LN, Paulsson B, Mullen J, Vagero AM. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 2004;24:599606.
  • 19
    Gangadhar BN, Desai NG, Channabasvanna SM. Potentiation of lithium with carbamazepine in acute mania. Indian J Psychiatry 1987;29:7375.
  • 20
    Chou JC, Czobor P, Charles O, Tuma I, Winsberg B, Allen MH, Trujillo M et al. Acute mania: haloperidol dose and augmentation with lithium or lorazepam. J Clin Psychopharmacol 1999;19:500505.
  • 21
    Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002;41:12161223.
  • 22
    Garfinkel PE, Stancer HC, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 1980;2:279288.
  • 23
    Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159:11461154.
  • 24
    Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, Sweitzer DE. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2004;6:213223.
  • 25
    Small JG, Klapper MH, Marhenke JD, Milstein V, Woodham GC, Kellams JJ. Lithium combined with carbamazepine or haloperidol in the treatment of mania. Psychopharmacol Bull 1995;31:265272.
  • 26
    Tohen M, Chengappa KN, Suppes T, Zarate CA Jr, Calabrese JR, Bowden CL, Sachs GS et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002;59:6269.
  • 27
    Weisler R, Dunn J, English P. Ziprasidone in adjunctive treatment of acute mania: a randomised, double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003;13(suppl. 4):S344S345.
  • 28
    Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 2003;182:141147.
  • 29
    Muller-Oerlinghausen B, Retzow A, Henn FA, Giedke H, Walden J. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group. J Clin Psychopharmacol 2000;20:195203.